Effects of nedocromil sodium in steroid-resistant asthma: A randomized controlled trial

Journal of Allergy and Clinical Immunology

Volumn 97, Issue 2, 1996, Pages 602-610

  Marin, Jose M ^a   Carrizo, Santiago J ^b   Garcia, Rosa ^b   Ejea, Maria V ^b  

^a HOSPITAL UNIVERSITARIO MIGUEL SERVET   (Spain)

^b NONE

Author keywords

asthma treatment; nedocromil sodium; Steroid resistant asthma

Indexed keywords

BECLOMETASONE; BUDESONIDE; NEDOCROMIL; PREDNISOLONE; SALBUTAMOL; THEOPHYLLINE;

ADOLESCENT; ADULT; ARTICLE; ASTHMA; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG RESPONSE; FEMALE; HUMAN; INFLAMMATION; INHALATIONAL DRUG ADMINISTRATION; MALE; ORAL DRUG ADMINISTRATION; PEAK EXPIRATORY FLOW; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; STEROID THERAPY; TREATMENT OUTCOME;

EID: 0030025824     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-6749(96)70305-6     Document Type: Article

References (29)

1. Barnes PJ. A new approach to the treatment of asthma. N EngI J Med 1989;321:1517-27.
2. British Thoracic Society, Research Unit of The Royal College of Physicians of London, King's Fund Center, National Asthma Campaign. Guidelines for management of asthma in adults. I. Chronic persistent asthma. Br Med J 1990;301:651-4.
3. National Heart, Lung, and Blood Institute, National Institutes of Health. Guidelines for the diagnosis and management of asthma. Washington, DC: US Department of Health and Human Services, 1991. publication no. 91-3042.
4. Carmichael J, Peterson IC, Diaz P, Crompton GK, Kay AB, Grant IWB. Corticosteroid resistence in asthma. Br Med J 1981;282:1419-22.
5. Cypcar D, Busse WW. Steroid-resistant asthma. J ALLERGY CLIN IMMUNOL 1993;92:362-72.
6. Lane JJ, Lee TH. Glucocorticoid receptor characteristics in monocytes of patients with corticosteroid-resistant bronchial asthma. Am Rev Respir Dis 1991;143:1020-4.
7. Wilkinson JRW, Crea AEG, Clark TJH, Lee TH. Identification and characterisation of monocyte-derived neutrophil-activating factor in corticosteroid-resistant bronchial asthma. J Clin Invest 1989;84:1930-41.
8. Brown PH, Teelucksingh S, Matusiewicz SP, Greening AP, Crompton GK, Edwards CRW. Cutaneous vasoconstrictor response to glucocorticoids in asthma. Lancet 1991;337:576-80.
9. Okret S, Dong Y, Brönnegard M, Gustafsson J-A. Regulation of glucocorticoid receptor expression. Biochimie 1991;73:51-9.
10. Thomson NC. Nedocromil sodium: an overview. Respir Med 1989;83:269-76.
11. American Thoracic Society. Chronic bronchitis, asthma, and pulmonary emphysema. Am Rev Respir Dis 1987;136:224-5.
12. Juniper EF, Guyatt GH, Epstein RS, Ferrie PJ, Jaeschke R, Hiller TK. Evaluation of impairment of health related quality of life in asthma: development of a questionnaire for use in clinical trials. Thorax 1992;47:76-83.
13. Cherniack RM, Wasserman SF, Ramsdell JW, et al. A double-blind multicenter group comparative study of the efficacy and safety of nedocromil sodium in the management of asthma. Chest 1990;97:1299-306.
14. Bel EH, Timmers MC, Hermans J, Dijkman JH, Sterk PJ. The long-term effects of nedocromil sodium and beclomethasone dipropionate on bronchial responsiveness to methacholine in nonatopic asthmatic subjects. Am Rev Respir Dis 1990;141:21-8.
15. Callaghan B, Teo NC, Clancy L. Effects of the addition of nedocromil sodium to maintenance bronchodilator therapy in the management of chronic asthma. Chest 1992;101:787-92.
16. Lal S, Dorow PD, Venho KK, Chatterjee SS. Nedocromil sodium is more effective than chromolyn sodium for the treatment of chronic reversible obstructive airway disease. Chest 1993;104:438-47.
17. Fink JN, Forman S, Silvers WS, Soifer MM, Tashkin DP, Wilson AF. A double-blind study of the efficacy of nedocromil sodium in the management of asthma in patients using high doses of bronchodilators. J ALLERGY CLIN IMMUNOL 1994;94:473-81.
18. De Jong JW, Teengs JP, Postma DS, Van der Mark TW, Koëter GH, De Monchy JGR. Nedocromil sodium versus albuterol in the management of allergic asthma. Am J Respir Crit Care Med 1994;149:91-7.
19. Bone MF, Kubik MM, Keaney NP, et al. Nedocromil sodium in adults with asthma dependent on inhaled corticosteroids: a double blind, placebo controlled study. Thorax 1989;44:654-9.
20. Rebuck AS, Kesten S, Boulet, et al. A 3-month evaluation of the efficacy of nedocromil sodium in asthma: a randomized, double-blind, placebo-controlled trial of nedocromil sodium conducted by a Canadian multicenter study group. J ALLERGY CLIN IMMUNOL 1990;85:612-7.
21. Alexander AG, Barnes NC, Kay AB. Trial of cyclosporine in corticosteroid-dependent chronic severe asthma. Lancet 1992;339:324-8.
22. Shiner RJ, Nunn A, Churg KF, Geddes DM. Steroid-sparing effect of methotrexate in the treatment of chronic severe asthma: a double-blind controlled study. Lancet 1990;336:136-40.
23. Corrigan CG, Brown PH, Barnes NC, et al. Glucocorticoid resistance in chronic asthma. Glucocorticoid pharmacokinettics, glucocorticoid receptor characteristics, and inhibition of peripheral blood T cell proliferation by glucocorticoid in vitro. Am Rev Respir Dis 1991;144:1016-25.
24. Kahan BD. Cyclosporine. N Engl J Med 1989;321:1725-38.
25. Poznansky MC, Gordon ACH, Grant IWB, Wyllie AH. A cellular abnormality in glucocorticoid-resistant asthma. Clin Exp Immunol 1985;61:135-42.
26. Alvarez J, Surs W, Leung DYM, Ikle D, Gelfand EM, Szefler SJ. Steroid-resistant asthma: immunologic and pharmacologic features. J ALLERGY CLIN IMMUNOL 1992;89:714-21.
27. Lane SJ, Wilkinson JRW, Cochrane GM, Lee TH, Arm JP. Differential in vitro regulation by glucocorticoids of monocyte-derived cytokine generation in glucocorticoid-resistance bronchial asthma. Am Rev Respir Dis 1993;147:690-6.
28. Mekori YA, Baram D, Goldberg A, Hershkoviz R, Reshef T, Sredni D. Nedocromil sodium inhibits T-cell function in vitro and in vivo. J ALLERGY CLIN IMMUNOL 1993;91:817-24.
29. Barnes PJ, Pedersen S. Efficacy and safety of inhaled corticosteroids m asthma. Am Rev Respir Dis 1993;148:S1-26.